Navigation Links
Dr. Philip A. DeFina of International Brain Research Foundation Joins Montgomery Academy Board of Trustees
Date:6/11/2009

Chester Township scientist, author and lecturer lends his expertise to special ed school

MENDHAM TOWNSHIP, N.J., June 11 /PRNewswire-USNewswire/ -- Montgomery Academy's Board of Trustees voted unanimously during its May meeting to name Dr. Philip A. DeFina to the Board of the nonprofit, state approved school.

Dr. DeFina founded the nonprofit International Brain Research Foundation and serves as both its Chief Executive Officer and Chief Scientific Officer. He has been a Guest Researcher at the National Institute of Health and a member of the International Neuroscience Subcommittee of the World Health Organization. A pioneer in developing and directing clinical training programs in the cognitive neurosciences, Dr. DeFina has worked to develop groundbreaking treatments for traumatic brain injury, coma, Alzheimer's, autism and Parkinson's. DeFina, himself an Army veteran, has revived over forty patients from minimally conscious or vegetative states including five injured U.S. soldiers. He has worked in collaboration with the Department of Defense and is the chief consultant for the traumatic brain injury program at Kessler Institute for Rehabilitation. His treatment protocols include electronic brain stimulation and hyperbaric oxygen induction, among other therapies, to help balance the electrical and chemical activity in the brain.

"It is a great honor to have Phil join Montgomery Academy's Board," said J. Anthony Manger of Norris, McLaughlin & Marcus, P.A., who chairs the Board of Trustees and also serves as an officer of its Foundation. "Phil's powerful and cutting edge work in neuroscience and brain health makes him particularly well suited to guide this gem of a school as it enters its 40th year of service to classified and autistic students. We are absolutely thrilled that he's accepted our invitation to join the Board and look forward to partnering with him to promote his vitally important brain research. Phil has written texts on educational neuropsychology and assessment and specializes in learning disabilities, psychiatric and autism spectrum disorders which affect Montgomery Academy students and many youngsters in our state."

Montgomery Academy delivers individualized instruction, counseling, transition, performing arts, athletics, technology, social skills and summer programs to students from over fifty sending districts in eight New Jersey counties. Its mission is to support and nurture youngsters who have emotional, behavioral and learning challenges that have not been met in conventional public school settings. It's a place where students can truly be themselves -- guided toward self-confidence, self-governance and self-knowledge in a reassuring atmosphere of trust and mutual respect. Making choices, cultivating interests: these are at the heart of the Montgomery Academy experience. To learn more about how Montgomery Academy creates opportunity for students with disabilities, please visit www.montgomeryacademyonline.org or call the school at 908.234.2840.


'/>"/>
SOURCE Montgomery Academy Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
2. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
3. Audio from Medialink and Philips: Americas Dirty Mouths
4. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
5. AUDIO from Medialink and Philips: Getting Rid of the Uninvited Holiday Guests on Your Toothbrush
6. North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign
7. Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
8. Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use
9. Philip Coelho Joins Mediware Board
10. VIDEO from Medialink and Philips: Philips Electronics Unveils First Imagination Light Canvas at the New Mercy Medical Center in Rogers AR
11. Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Axiad IDS , a leading ... Applications magazine has named the company a “Top 25 Cybersecurity Companies 2017.” ... to help organizations simply and proactively address potential cybersecurity threats before they happen. ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... technology and a 2017 Best in KLAS category winner, has named Daniel P. ... to extend and enhance its technology platform and product offerings,” says Justin Neece, ...
(Date:5/23/2017)... ... May 23, 2017 , ... Drs. ... on peri-implantitis in Las Vegas, NV, and the importance of treating ... disease consultation and leading care for peri-implantitis, with or without a referral. As ...
(Date:5/23/2017)... ... May 23, 2017 , ... New patients with symptoms of gum disease ... receive laser gum disease treatments from the doctors at Art of Dentistry, without first ... awareness of the importance of receiving qualified treatment in order to avoid systemic health ...
(Date:5/22/2017)... ... May 22, 2017 , ... Patients who avoid necessary dental and ... dentistry in Mt. Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of ... treatments. One or more sedation methods may be recommended based on the severity of ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
(Date:5/10/2017)... -- The Corporate Whistleblower Center says, "We are urging ... to call us anytime at 866-714-6466 if they possess ... a substantial scheme to overbill Medicare. We are ... of a medical equipment company if their employer ... practice groups with extra generous incentives to use, or ...
(Date:5/9/2017)... 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... Property Office has granted Oramed a patent titled, ... The patent covers Oramed,s invention of an oral ... an incretin hormone that stimulates the secretion of ...
Breaking Medicine Technology: